Document Detail


Inhibition of neutrophil activity in cardiac surgery with cardiopulmonary bypass: a novel strategy with the leukocyte inhibition module.
MedLine Citation:
PMID:  15072250     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recently, we showed that the arterial in-line application of the leukocyte inhibition module (LIM) within the heart-lung machine limits overshooting leukocyte activity and cardiac tissue damage. Moreover, significantly better cardiac function was found in an experimental animal model when LIM was used. In the meantime, the first promising clinical data exist. LIM has to be regarded as an essential tool in extracorporeal circulation, in the future, to improve postoperative clinical outcome and to reduce costs. This review summarizes the biological background of LIM and the current experience obtained in experimental models and clinical studies.
Authors:
José Bitu Moreno; Stefan Margraf; Alina M Schuller; A Simon; A Moritz; M Scholz
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Perfusion     Volume:  19     ISSN:  0267-6591     ISO Abbreviation:  Perfusion     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2004-04-09     Completed Date:  2004-10-05     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8700166     Medline TA:  Perfusion     Country:  England    
Other Details:
Languages:  eng     Pagination:  11-6     Citation Subset:  IM    
Affiliation:
Department of Vascular Surgery, Medical Faculty of Marília (FAMEMA), Sao Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibodies, Monoclonal / administration & dosage
Antigens, CD95 / immunology
Cardiac Surgical Procedures*
Cardiopulmonary Bypass*
Coated Materials, Biocompatible
Extracorporeal Circulation
Filtration / instrumentation
Humans
Leukapheresis / instrumentation*
Leukocytes
Neutrophil Activation* / drug effects
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antigens, CD95; 0/Coated Materials, Biocompatible

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Does the use of leucocyte depletion during cardiopulmonary bypass affect exhaled nitric oxide produc...
Next Document:  Experience with the Jostra Rotaflow and QuadroxD oxygenator for ECMO.